Review of Immunotherapy Landscape and Importance of Biomarkers

Critical next steps to optimize your clinical trial design

Immunotherapies provide huge potential to fight against cancer. This presentation provides an overview of the immunotherapy landscape and growth of trials, lessons learned from past trials, as well as selecting the appropriate biomarker strategy to optimize trial design.

Victor Weigman, Ph.D., Director Translational Genomics